Copyright © 2002 by the European Society of Cardiology.
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
a Department of Medicine, Brigham and Women's Hospital, Boston, MA, U.S.A.
b Merck & Co. Whitehouse Station, NJ, U.S.A.
c Montreal Heart Institute, Montreal, Canada
revised April 9, 2001; accepted April 11, 2001
Abstract
Aims We evaluated the TIMI Risk Score for Unstable Angina and Non-ST Elevation Myocardial Infarction for predicting clinical outcomes and the efficacy of tirofiban in non-ST elevation acute coronary syndromes.
Methods and Results Developed in TIMI 11B, the risk score is calculated as the sum of seven presenting characteristics (age 
65 years, 3 cardiac risk factors, documented coronary disease, recent severe angina, ST deviation 0·5mm, elevated cardiac markers, prior aspirin use). The risk score was validated in the PRISM-PLUS database (n=1915) and tested for interaction with the efficacy of tirofiban+heparin vs heparin alone. The risk score revealed an increasing gradient of risk for death, myocardial infarction or recurrent ischaemia at 14 days ranging from 7·7–30·5% (P<0·001). Dichotomized at the median, patients with a score 4 derived a greater relative risk reduction with tirofiban (P(Interaction)=0·025). Among patients with normal creatine kinase myocardial bands, the risk score showed a 3·5-fold gradient of risk (P<0·001) and identified a population that derived significant benefit from tirofiban (RR 0·73,P =0·027).
Conclusion The TIMI Risk Score is a simple clinical tool for risk assessment that may aid in the early identification of patients who should be considered for treatment with potent antiplatelet therapy.
Key Words: coronary disease, prognosis, myocardial infarction, unstable angina, platelet inhibitors
f1 Correspondence: David A. Morrow, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, U.S.A.
References
- Bertrand ME, Simoons ML, Fox KA. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406–1432
[Free Full Text] - Braunwald E, Antman EM, Beasley JW. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2000;36:970–1062
[Free Full Text] - Maseri A, Cianflone D, Paceri V, Crea F. The risk and cost-effective individual patient management: the challenge of a new generation of clinical trials. Cardiovasc Drugs Ther. 1997;10:751–758[CrossRef][ISI][Medline]
- Antman EM, Cohen M, Bernink PJ. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842
[Abstract/Free Full Text] - Boersma E, Pieper KS, Steyerberg EW. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101:2557–2567
[Abstract/Free Full Text] - Lee KL, Woodlief LH, Topol EJ. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 1995;91:1659–1668
[Abstract/Free Full Text] - Antman EM, Tanasijevic MJ, Thompson B. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
[Abstract/Free Full Text] - Cannon CP, McCabe CH, Stone PH. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol. 1997;30:133–140[Abstract]
- Maseri A, Rebuzzi AG, Cianflone D. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation. 1997;96:4141–4142
- Antman EM, McCabe CH, Gurfinkel EP. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601
[Abstract/Free Full Text] - N Engl J Med. 1998;338:1488–1497
[Abstract/Free Full Text] - Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
[Abstract/Free Full Text] - Hosmer, DW, Lemeshow, S, Applied Logistic Regression, New York, John Wiley & Sons, Inc. 1989
- Bhatt DL, Marso SP, Houghtaling P, Labinaz M, Lauer MA. Does earlier administration of eptifibatide reduce death and MI in patients with acute coronary syndromes? (Abstr). Circulation. 1998;98:I-560
- Januzzi JL, Hahn SS, Chae CU. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol. 2000;86:713–717[CrossRef][ISI][Medline]
- Alexander JH, Sparapani RA, Mahaffey KW. Eptifibatide reduces the size and incidence of myocardial infarction in patients with non-ST-elevation acute coronary syndromes [abstract]. J Am Coll Cardiol. 1999;33:331A
- Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757–1762[CrossRef][ISI][Medline]
- Morrow DA, Antman EM, Tanasijevic J. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI 11B sub-study. J Am Coll Cardiol. 2000;36:1812–1817
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. A. Harrington, R. C. Becker, C. P. Cannon, D. Gutterman, A. M. Lincoff, J. J. Popma, G. Steg, G. H. Guyatt, and S. G. Goodman Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 670S - 707S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 American College of Cardiology/American Heart Asso, 2007 Writing Group to Review New Evidence and Upda, S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, and D. O. Williams 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention J. Am. Coll. Cardiol., January 15, 2008; 51(2): 172 - 209. [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, D. O. Williams, 2005 WRITING COMMITTEE MEMBERS, S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee Circulation, January 15, 2008; 117(2): 261 - 295. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kent and R. A. Hayward Limitations of Applying Summary Results of Clinical Trials to Individual Patients: The Need for Risk Stratification JAMA, September 12, 2007; 298(10): 1209 - 1212. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karounos, A. M. Chang, J. L Robey, K. L Sease, F. S Shofer, C. Follansbee, and J. E Hollander TIMI risk score: does it work equally well in both males and females? Emerg. Med. J., July 1, 2007; 24(7): 471 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Yan, R. T. Yan, M. Tan, A. Casanova, M. Labinaz, K. Sridhar, D. H. Fitchett, A. Langer, and S. G. Goodman Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better Eur. Heart J., May 1, 2007; 28(9): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jeetley, L. Burden, B. Stoykova, and R. Senior Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study Eur. Heart J., January 16, 2007; (2007) ehl444v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Marso, D. M. Safley, J. A. House, T. Tessendorf, K. J. Reid, and J. A. Spertus Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death: Identification of a new high-risk acute coronary syndrome population Diabetes Care, August 1, 2006; 29(8): 1931 - 1932. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jeetley, L. Burden, and R. Senior Stress echocardiography is superior to exercise ECG in the risk stratification of patients presenting with acute chest pain with negative Troponin Eur J Echocardiogr, March 1, 2006; 7(2): 155 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Glaser, H. A. Glick, H. C. Herrmann, and S. E. Kimmel The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes: A Cost-Effectiveness Analysis J. Am. Coll. Cardiol., February 7, 2006; 47(3): 529 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.L. Soiza, S.J. Leslie, P. Williamson, S. Wai, K. Harrild, N.R. Peden, and A.D. Hargreaves Risk stratification in acute coronary syndromes--does the TIMI risk score work in unselected cases? QJM, February 1, 2006; 99(2): 81 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Das, N Kilcullen, C Morrell, M B Robinson, J H Barth, A S Hall, and on behalf of the EMMACE-2 (evaluation of methods a The British Cardiac Society Working Group definition of myocardial infarction: implications for practice Heart, January 1, 2006; 92(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Devlin, F A Anderson, S Heald, J Lopez-Sendon, A Avezum, J Elliott, O H Dabbous, D Brieger, and for the GRACE Investigators Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry Heart, November 1, 2005; 91(11): 1394 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N S Kleiman and H D White The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes Heart, September 1, 2005; 91(9): 1121 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S J Walsh, M S Spence, D Crossman, and A A J Adgey Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond Heart, September 1, 2005; 91(9): 1135 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. de Araujo Goncalves, J. Ferreira, C. Aguiar, and R. Seabra-Gomes TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS Eur. Heart J., May 1, 2005; 26(9): 865 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-K. Wong and H. D. White Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes Eur. Heart J., May 1, 2005; 26(9): 851 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 G A Large Contemporary management of acute coronary syndrome Postgrad. Med. J., April 1, 2005; 81(954): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Garcia, M. J. Canoniero, J. A. Chirinos, E. de Marchena, T. Salerno, and A. Ferreira Development of a Score to Predict the Need for Coronary Artery Bypass Graft Surgery in Patients With Non-ST Segment Elevation Acute Coronary Syndromes Ann. Thorac. Surg., December 1, 2004; 78(6): 2022 - 2026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Popma, P. Berger, E. M. Ohman, R. A. Harrington, C. Grines, and J. I. Weitz Antithrombotic Therapy During Percutaneous Coronary Intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 576S - 599S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Wiviott, D. A. Morrow, P. D. Frederick, R. P. Giugliano, C.M. Gibson, C. H. McCabe, C. P. Cannon, E. M. Antman, and E. Braunwald Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: A simple index that predicts mortality in ST-segment elevation myocardial infarction J. Am. Coll. Cardiol., August 18, 2004; 44(4): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Blazing, J. A. de Lemos, H. D. White, K. A. A. Fox, F. W. A. Verheugt, D. Ardissino, P. M. DiBattiste, J. Palmisano, D. W. Bilheimer, S. M. Snapinn, et al. Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial JAMA, July 7, 2004; 292(1): 55 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Sabatine, D. A. Morrow, R. P. Giugliano, S. A. Murphy, L. A. Demopoulos, P. M. DiBattiste, W. S. Weintraub, C. H. McCabe, E. M. Antman, C. P. Cannon, et al. Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial Circulation, February 24, 2004; 109(7): 874 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald Application of Current Guidelines to the Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction Circulation, October 21, 2003; 108(90161): III-28 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow Review Article: Treatment of Unstable Angina Pectoris/Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2003; 58(10): M927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon and A. G.G. Turpie Unstable Angina and Non-ST-Elevation Myocardial Infarction: Initial Antithrombotic Therapy and Early Invasive Strategy Circulation, June 3, 2003; 107(21): 2640 - 2645. [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: Insights from the TACTICS TIMI-18 trial J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 43S - 48S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Sabatine and E. M. Antman The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 89S - 95S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1366 - 1374. [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) Circulation, October 1, 2002; 106(14): 1893 - 1900. [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon Evidence-Based Risk Stratification to Target Therapies in Acute Coronary Syndromes Circulation, September 24, 2002; 106(13): 1588 - 1591. [Full Text] [PDF]
|
|
|
|
|
|
A. Budaj, S. Yusuf, S. R. Mehta, K. A.A. Fox, G. Tognoni, F. Zhao, S. Chrolavicius, D. Hunt, M. Keltai, M. G. Franzosi, et al. Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups Circulation, September 24, 2002; 106(13): 1622 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. White and C. K. Wong Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes Eur. Heart J., February 1, 2002; 23(3): 187 - 191. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||